Language
English
Publication Date
3-13-2024
Journal
Cardiovascular Research
DOI
10.1093/cvr/cvae002
PMID
38175760
PMCID
PMC10936750
PubMedCentral® Posted Date
1-4-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Aims: Gene therapies to induce cardiomyocyte (CM) cell cycle re-entry have shown a potential to treat subacute ischaemic heart failure (IHF) but have not been tested in the more relevant setting of chronic IHF. Our group recently showed that polycistronic non-integrating lentivirus encoding Cdk1/CyclinB1 and Cdk4/CyclinD1 (TNNT2-4Fpolycistronic-NIL) is effective in inducing CM cell cycle re-entry and ameliorating subacute IHF models and preventing the subsequent IHF-induced congestions in the liver, kidneys, and lungs in rats and pigs. Here, we aim to test the long-term efficacy of TNNT2-4Fpolycistronic-NIL in a rat model of chronic IHF, a setting that differs pathophysiologically from subacute IHF and has greater clinical relevance.
Methods and results: Rats were subjected to a 2-h coronary occlusion followed by reperfusion; 4 weeks later, rats were injected intramyocardially with either TNNT2-4Fpolycistronic-NIL or LacZ-NIL. Four months post-viral injection, TNNT2-4Fpolycistronic-NIL-treated rats showed a significant reduction in scar size and a significant improvement in left ventricular (LV) systolic cardiac function but not in the LV dilatation associated with chronic IHF. A mitosis reporter system developed in our lab showed significant induction of CM mitotic activity in TNNT2-4Fpolycistronic-NIL-treated rats.
Conclusion: This study demonstrates, for the first time, that TNNT2-4Fpolycistronic-NIL gene therapy induces CM cell cycle re-entry in chronic IHF and improves LV function, and that this salubrious effect is sustained for at least 4 months. Given the high prevalence of chronic IHF, these results have significant clinical implications for developing a novel treatment for this deadly disease.
Keywords
Rats, Animals, Swine, Myocardial Ischemia, Heart Failure, Myocytes, Cardiac, Chronic Disease, Genetic Therapy, Cell Cycle, Cell cycle, Heart failure, Cardiomyocyte
Published Open-Access
yes
Recommended Citation
Abouleisa, Riham R E; Tang, Xian-Liang; Ou, Qinghui; et al., "Gene Therapy Encoding Cell Cycle Factors to Treat Chronic Ischemic Heart Failure in Rats" (2024). Faculty, Staff and Students Publications. 8619.
https://digitalcommons.library.tmc.edu/baylor_docs/8619